CLAXTON HEPBURN MEDICAL CENTER — History
CCN 330211 | 3-year financial timeline | COVID resilience: 53/100
🛡️ Public data only — no PHI permitted on this instance.
$107M
Latest Revenue (FY2022)
+9.0%
Revenue CAGR (3yr)
-16.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $90M | $100M | $107M | +7.0% | +9.0% |
| Operating Expenses | $99M | $118M | $124M | +4.8% | +11.7% |
| Operating Margin | -10.6% | -18.4% | -16.0% | +13.1% | +0.0% |
| Net Income | $-10M | $-18M | $-17M | +7.0% | +0.0% |
| Licensed Beds | 38 | 38 | 38 | +0.0% | +0.0% |
| Total Patient Days | 7,690 | 10,250 | 9,638 | -6.0% | +12.0% |
| Medicare Day % | 45% | 36% | 33% | -8.1% | -14.0% |
| Medicaid Day % | 3% | 2% | 1% | -47.1% | -43.8% |
COVID Impact & Recovery
Resilience Score: 53/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +18.9% ($90M → $107M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+9.0%
This Hospital
+7.6%
State Avg
Latest Margin
-16.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $115M | -18.7% |
| FY2024 (proj) | $124M | -21.4% |
| FY2025 (proj) | $132M | -24.2% |